Welcome to the SANADII Trial Website
SANAD II trial is now closed to recruitment!
Follow-up of trial participants continues.
SANADII is a clinical trial designed to identify the most effective and cost-effective treatment for patients (adults and children over 5 years) with newly-diagnosed epilepsy.
The majority of the content of this website is aimed at patients and their families, but trial staff can access the randomisation website and other specific information via the ‘Researchers’ link on the left.
This trial is co-sponsored by the University of Liverpool and The Walton Centre for Neurology and Neurosurgery NHS foundation Trust, funded by the National Institute for Health Research Health Technology Assessment Programme (NIHR HTA) and coordinated by the Clinical Trials Research Centre – University of Liverpool.
SANAD II randomised its first patient on the 30th April 2013 at Alder Hey Children's Hospital and has now recruited 1510 participants from 94 opened sites.
SANADII is a clinical trial designed to identify the most effective and cost-effective treatment for patients (adults and children over 5 years) with newly-diagnosed epilepsy.
The majority of the content of this website is aimed at patients and their families, but trial staff can access the randomisation website and other specific information via the ‘Researchers’ link on the left.
This trial is co-sponsored by the University of Liverpool and The Walton Centre for Neurology and Neurosurgery NHS foundation Trust, funded by the National Institute for Health Research Health Technology Assessment Programme (NIHR HTA) and coordinated by the Clinical Trials Research Centre – University of Liverpool.
SANAD II randomised its first patient on the 30th April 2013 at Alder Hey Children's Hospital and has now recruited 1510 participants from 94 opened sites.
View SANAD II Recruiting Centres in a full screen map
